SOUTH SAN FRANCISCO, CA, USA I 05, 2024 I Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing in a global Phase 2a clinical ...
This study provides valuable evidence for the mechanism underlying KCNC1-related developmental and epileptic encephalopathy. The authors have generated and characterized a new knock-in mouse with a ...
Figure 1: The predicted protein sequence of JMC8. Expression of JMC8 was assessed by PCR amplification of a QUICK-Screen Human cDNA Library panel (Clontech) using exon primers from exons 24 and 33 ...